New Hypothyroidism Weeks After an Adrenal Crisis: When to Start Levothyroxine
A single patient whose adrenal replacement appears stable only three weeks after the crisis that revealed it, now facing a second hormone deficiency whose treatment carries a real, specific risk to the first.
Josephine T., a 26-year-old veterinary technician, was diagnosed with autoimmune Addison's disease three weeks ago after a hospitalization for what turned out to be her first adrenal crisis — hyponatremic, hypotensive, and profoundly fatigued in a way she'd been dismissing for months as overwork, blaming long shifts and a new puppy at home that wasn't sleeping through the night any more than she was. Hydrocortisone and fludrocortisone have made a real, immediate difference; she describes finally feeling like herself again for the first time since the spring, and has already started asking when she can pick up extra shifts at the clinic again. What complicates her picture is a TSH drawn during the same admission, part of the routine autoimmune-screen reflex her admitting team ordered given how often adrenal and thyroid autoimmunity travel together: 9.8 mIU/L, unambiguously elevated, with a free T4 at the low end of normal — new, previously undiagnosed primary hypothyroidism, autoimmune polyglandular syndrome type 2 rather than isolated Addison's disease.
The actual clinical question isn't whether she needs levothyroxine — she clearly does — it's when to start it relative to her adrenal replacement, and the sequencing is not a minor detail. The 2016 Endocrine Society guideline (Bornstein et al.) is explicit that glucocorticoid replacement must be established before thyroid hormone in this situation, for a concrete reason: levothyroxine accelerates cortisol metabolism and clearance, so starting it before her glucocorticoid replacement is fully established risks precipitating an adrenal crisis in a patient whose own adrenal reserve is already zero, by unmasking a relative glucocorticoid deficiency that her body, still producing no cortisol of its own, cannot compensate for. She is three weeks into hydrocortisone at what appears to be an adequate, stable dose, but "appears stable" and "confirmed adequate through a period of added thyroid-hormone-driven metabolic demand" are not quite the same claim.
Endocrinology follow-up, reviewing new hypothyroidism
Her TSH is nearly 10, clearly elevated, and she's been stable on hydrocortisone for three weeks now. I'd start levothyroxine at a low dose today rather than leave a confirmed second diagnosis untreated while we wait for some further confirmation of stability.
I want to be careful about what "stable" means here. She has zero residual adrenal reserve, and thyroid hormone replacement accelerates cortisol clearance — that's the exact mechanism that can unmask relative glucocorticoid deficiency in a patient whose body can't compensate for it on its own. Three weeks of feeling well on her current dose isn't the same as knowing that dose holds up once we add thyroid-hormone-driven metabolic demand on top of it. Her crisis three weeks ago is a direct demonstration of how thin her margin actually is.
I'm not saying never treat her hypothyroidism — I'm saying the sequencing here isn't a formality, it's the same mechanism that put her in the hospital in the first place.
The risk scales with how much and how fast we increase her thyroid hormone, not with whether we start it at all. Start levothyroxine at a genuinely low dose — well below a full replacement dose — and watch her hydrocortisone response closely through the transition rather than waiting indefinitely or starting at a dose that maximizes the clearance effect all at once. That treats her real, diagnosed hypothyroidism without ignoring the real mechanism behind her recent crisis.
Agreed: start levothyroxine at a low dose with hydrocortisone held stable and closely monitored through the transition, titrating thyroid hormone upward gradually based on repeat labs.
Not agreed: how long to wait before increasing the levothyroxine dose toward full replacement. The primary care physician would follow the standard six-week interval regardless; the endocrinologist wants an additional, earlier symptom check specifically for adrenal insufficiency signs before any dose increase, even if labs alone would otherwise support moving faster.